Cancer-associated thromboses in non-small cell lung cancer patients with epidermal growth factor receptor mutation
<i>EGFR</i>-positive patients are currently treated with tyrosine kinase inhibitors and are expected to have a certain long-term prognosis. However, there is concern that overall survival might be shortened if CATs develop. Therefore, the possibility of developing CATs in <i>EGFR</i>-positive NSCLC patients must be addressed.
Authors
- Takeo Endo
- Nobuyuki Hizawa (ORCID: https://orcid.org/0000-0003-1822-2448)
- Manato Taguchi
- Yosuke Maezawa
- Takeshi Kawakami (ORCID: https://orcid.org/0000-0001-9385-9516)
- Ryota Nakamura (ORCID: https://orcid.org/0000-0001-9519-2276)
- Kunihiko Miyazaki (ORCID: https://orcid.org/0000-0001-7047-5595)
- Hiroaki Satoh (ORCID: https://orcid.org/0000-0002-1561-1723)
- Tohru Sakamoto (ORCID: https://orcid.org/0000-0002-8876-1466)
- Takeshi Numata
- Toshihide Inui
- Toshihiro Shiozawa
Institutions
- University of Tsukuba (JP)
- National Hospital Organization Mito Medical Center (JP)
- Tsukuba Memorial Hospital (JP)
- Kobari General Hospital (JP)
Publication Details
- Journal
- Współczesna Onkologia
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5114/wo.2025.155693
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00